Document is current
Any future updates will be listed below
-
Authors
Mastrangelo, Annalaura https://orcid.org/0000-0003-2650-0444
Robles-Vera, Iñaki https://orcid.org/0000-0001-6002-9241
Mañanes, Diego https://orcid.org/0000-0001-7247-6794
Galán, Miguel https://orcid.org/0000-0002-6695-1509
Femenía-Muiña, Marcos
Redondo-Urzainqui, Ana
Barrero-Rodríguez, Rafael
Papaioannou, Eleftheria
Amores-Iniesta, Joaquín
Devesa, Ana https://orcid.org/0000-0001-5981-2546
Lobo-González, Manuel
Carreras, Alba
Beck, Katharina R.
Ivarsson, Sophie https://orcid.org/0009-0009-4050-9075
Gummesson, Anders
Georgiopoulos, Georgios
Rodrigo-Tapias, Manuel
Martínez-Cano, Sarai
Fernández-López, Ivan
Nuñez, Vanessa
Ferrarini, Alessia https://orcid.org/0000-0002-4587-6095
Inohara, Naohiro
Stamatelopoulos, Kimon
Benguría, Alberto https://orcid.org/0000-0002-5536-566X
Cibrian, Danay
Sánchez-Madrid, Francisco
Alonso-Herranz, Vanesa
Dopazo, Ana https://orcid.org/0000-0002-4910-1684
Barbas, Coral https://orcid.org/0000-0003-4722-491X
Vázquez, Jesús https://orcid.org/0000-0003-1461-5092
López, Juan Antonio https://orcid.org/0000-0002-9097-6060
González-Martín, Alicia
Nuñez, Gabriel
Stellos, Konstantinos https://orcid.org/0000-0002-0194-0825
Bergström, Göran https://orcid.org/0000-0003-4289-5722
Bäckhed, Fredrik
Fuster, Valentín
Ibañez, Borja https://orcid.org/0000-0002-5036-254X
Sancho, David https://orcid.org/0000-0003-2890-3984
- License Information
-
More Information
Article History
Received: 1 June 2023
Accepted: 9 June 2025
First Online: 16 July 2025
Change Date: 5 November 2025
Change Type: Update
Change Details: In the originally published version of this article, some of the source data contained a column with pseudonymized patient identification numbers. For privacy reasons, and in accordance with data protection requirements, this file has been replaced with an updated version in which the pseudonymized ID column has been removed, ensuring the data is now fully anonymized. We would like to emphasize that this correction does not affect the results, analyses, or conclusions of the study.
Competing interests
: F.B. receives research funding from Biogaia AB and Novo Nordisk A/S, is co-founder and shareholder of Roxbiosens Inc., and is on the scientific advisory board of Bactolife A/S. F.B., K.R.B. and A.C. are co-founders and shareholders of Implexion Pharma AB. A.M., I.R.-V., D.S., B.I., V.F. and D.M. are inventors on a patent application titled Antagonists of the I1R for use in the Prevention and/or Treatment of an Autoinflammatory or Autoimmune Disease , publication number WO2025002914 (2025). The other authors declare no competing interests.
